Drug intelligence / Profile preview

Xinkesu

Development stage: Preclinical
Lead developer: Compete Pharmaceutical
Administration: Oral

Overview

Xinkesu is a drug formulated as a capsule, currently undergoing clinical trials for the treatment of angina pectoris, particularly in patients presenting with the Traditional Chinese Medicine syndrome 'Qici Xueyu' zheng. The drug is being investigated for its efficacy in coronary heart disease and angina pectoris.

Other names: Xinkesu capsule心可舒胶囊

Beyond the preview

Go deeper on Xinkesu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinkesu.

Explore the full profile